Skip to content

Metabolic analysis of retinopathy of prematurity

Metabolic analysis of retinopathy of prematurity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020677
Enrollment
Unknown
Registered
2019-01-12
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retinopathy of prematurity

Interventions

Case series:Nil

Sponsors

Shenzhen Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Observation group: children with severe ROP requiring treatment; Control group: The premature who with infants gestational age ? 34w or premature birth weight <2000g and without ROP in the same neonatal intensive care unit (NICU) of observation group have the matched gestational age, birth weight and correct gestational age(birth weight difference is less than 200 g, birth gestational age difference less than 2 weeks, correct gestational age difference less than 2 weeks).

Exclusion criteria

Exclusion criteria: 1. Parents request to withdrew from the study or infants who have not completed ROP screening; 2. Congenital malformation genetic metabolic disease exists in preterm infants; 3. Severe complications (such as sepsis, necrotizing enterocolitis, neonatal respiratory distress syndrome, severe metabolic disorder, morbidity of the control group, etc.) or death occurred during the study; 4. The mother of the study subject has a history of serious diseases and medication during pregnancy; 5. The control group develop ROP in subsequent follow-up examinations.

Design outcomes

Primary

MeasureTime frame
biomarkers of blood of retinopathy of prematurity (ROP);

Contacts

Public ContactGuoming Zhang

Shenzhen eye hospital

13823509060@163.com+86 13823509060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026